Winstrol Injektion 50mg Shield Pharma

£57.00

Stanozolol injectable 50mg research formulation from Shield Pharma for laboratory investigations. High-purity synthetic anabolic compound suitable for controlled analytical studies and comparative research protocols.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Winstrol Injektion 50mg Shield Pharma
Winstrol Injektion 50mg Shield Pharma
£57.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview of Stanozolol Injectable Formulation

Stanozolol is a synthetic anabolic steroid derived from dihydrotestosterone, formulated here as a 50mg/ml injectable preparation by Shield Pharma. This laboratory-grade compound represents a significant tool for researchers studying anabolic pathways and steroid metabolism. Scientists at Stroid UK Shop can utilise this formulation to examine the structural properties and biochemical interactions of modified steroid molecules. The injectable format provides consistent concentrations for controlled experimental conditions, making it particularly valuable for comparative studies involving steroid receptor binding affinities and metabolic transformation pathways.

Laboratory Applications and Research Protocols

Research applications for stanozolol include investigating anabolic-androgenic ratios, studying protein synthesis modulation, and examining liver enzyme interactions. Laboratory protocols often involve analysing this compound’s effects on nitrogen retention mechanisms and its interaction with sex hormone-binding globulin. Researchers examining stanozolol preparations frequently compare its properties against other modified steroids to understand structural-activity relationships. The 50mg concentration allows for precise dilution studies and dose-response curve generation in cellular assays. Scientists may also investigate this compound alongside selective androgen receptor modulators to compare receptor selectivity patterns, or examine its interactions with growth factor peptides in tissue culture systems.

Technical Specifications

Stanozolol Injectable Research Specifications
Parameter Value
Active Compound Stanozolol
Concentration 50mg/ml
Manufacturer Shield Pharma
Form Injectable solution
CAS Number 10418-03-8
Molecular Formula C21H32N2O
Molecular Weight 328.49 g/mol
Storage Room temperature, protected from light

Research Compliance Statement

This stanozolol formulation is intended exclusively for in-vitro laboratory research and analytical studies. Not approved for human consumption, clinical use, or any applications outside controlled research environments. Researchers must comply with all applicable regulations governing steroid research compounds.

Related